ALX Oncology Holdings Inc. ALXO
1.11 USD -0.17 (-13.62%)
At closeNov 10, 2026, 4:00 PM EST
1.20 +0.09 +8.11%
After hours · Nov 10, 4:00 PM ET
1.11 Day range 1.25
0.862 52-week range 2.66
- YTD
- -1.77%
- 1 year
- -12.60%
Financial health
Altman Z-Score
-2.95 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E -0.6×
FY 2018 5y median -3.7× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 2.3×
FY 2018 5y median 2.3× FY 2025
P/FCF -0.7×
FY 2018 5y median -4.9× FY 2025
EV/EBITDA -0.5×
FY 2018 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -139.1%
FY 2018 5y median -20.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -391.4%
FY 2018 5y median -84.8% FY 2025
ROIC -262.0%
FY 2018 5y median -81.8% FY 2025
ROA -172.2%
FY 2018 5y median -66.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 27.0%
FY 2018 FY 2025
EPS (diluted) 26.4%
FY 2018 FY 2025
Free Cash Flow 31.1%
FY 2018 FY 2025
Financial Health
Current Ratio 2.1×
FY 2018 5y median 7.3× FY 2025
Quick Ratio 2.1×
FY 2018 5y median 7.3× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2018 5y median 0.1× FY 2025
Interest Coverage -64.9×
FY 2018 5y median -109× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
